Navigation Links
Marken Appoints New Directors To Board
Date:3/5/2013

RESEARCH TRIANGLE PARK, N.C., March 5, 2013 /PRNewswire/ -- Marken today announced that it has appointed two independent directors to its Board as a result of Marken's recent restructuring completed on December 21, 2012.  The appointment of Timothy C. Tyson and Michael O'Donnell is the next step in Marken's strategy to focus on serving the global life sciences industry.

(Logo:  http://photos.prnewswire.com/prnh/20110930/NY78064LOGO)

Tim Tyson is a veteran leader in the global pharmaceutical market place.  He currently serves as Chairman of the Board of Aptuit LLC, a global pharmaceutical services company based in the US.  He was CEO and President of Valeant Pharmaceuticals Inc. from 2003-2008.  Prior to that, Mr. Tyson held various leadership roles including as President, Global Manufacturing & Supply at GlaxoSmithKline (GSK).  During his 14 years at GSK, he led the Glaxo Dermatology and Cerenex Divisions, the US Marketing Division, and the US Sales Divisions where he launched 32 products, eight of which exceeded $1billion in global sales.  Mr. Tyson is an engineering graduate of the US Military Academy at West Point, and holds a masters degree in public administration from Jackson State University. He has held key positions on the PhRMA Board and the International Society of Professional Engineers (ISPE).

Michael O'Donnell currently serves as Chairman of Verna, a company specializing in infectious control products, and as non-executive Director of Helical Bar plc. a property development firm.  He has served as an independent Director on the Boards of seven companies since 2008 and also acted as a consultant to one of Marken's clients.  Prior to 2008, Mr. O'Donnell was a Managing Director of LGV Capital, a private equity firm, where he worked for more than a decade. He started his career at Morgan Grenfell where he worked for five years after graduating from University College, Dublin with a Bachelor of Commerce degree. 

"We are delighted to welcome Tim and Michael to Marken's Board of Directors," said Wes Wheeler , Marken's Chief Executive Officer.  "These two independent Directors will certainly provide us with an appropriate balance of deep industry and financial experience.  They also bring excellent contacts from the pharmaceutical industry and the UK financial markets, respectively, which will allow us to continue our expansion in the life sciences supply chain market." 

About Marken
Marken is the leading global clinical supply chain solutions provider dedicated to the pharmaceutical and life sciences industries, supporting over 49,000 clinical investigators in more than 150 countries. Marken integrates Depot and Logistics services into solutions that extend the reach of clinical trials to even the most remote treatment naive geographies.


'/>"/>
SOURCE Marken
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Marken Acquires European Kit Building Operation From LabCorp Clinical Trials
2. Marken Opens Branch Office In Seoul, South Korea
3. Marken Announces Global Advisory Board
4. Marken Launches New Global Regulatory Consultation Services
5. Marken Enhances Branch Operations
6. Marken Expands Regulatory And Technical Excellence In Logistics
7. Winner Medicals Special Committee Appoints Independent Financial Advisor and Retains Legal Counsel
8. Pro-Dex, Inc. Appoints Michael J. Berthelot Chief Executive Officer
9. Nephros Appoints John C. Houghton as President and Chief Executive Officer
10. Elsevier Appoints New President of Elsevier CPM Resource Center
11. GenWay Biotech Appoints New Vice President of Custom/OEM
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2017)... 2017 ivWatch, LLC, the leading provider of continuous monitoring ... has been awarded an Innovative Technology contract from Vizient, Inc., the ... ... in the early detection of peripheral IV infiltration and extravasation events ... The Innovative Technology contract was awarded to ...
(Date:8/28/2017)... , Aug. 28, 2017   Aesculight ®, a division of ... 2 surgical lasers. Built on over 20 years of American veterinary ... New and Exclusive VetScalpel®Features and Enhancements ... David Duclos, DVM, is excising a tumor with his new VetScalpel laser. ... in Lynnwood, WA. ...
(Date:8/24/2017)... BioBridges, a Career Portfolio® Management company providing ... to announce its corporate sponsorship of the upcoming fourth ... the event will benefit charitable foundations affiliated with each ... delighted to return once again as a sponsor of ... Jason Falchuk , BioBridges Founding Partner. "Our life ...
Breaking Medicine Technology:
(Date:9/21/2017)... ... 2017 , ... 38-Year-Old Plastic Surgeon Gill at Aesthetic Surgery Center is Saluted ... announce that Plastic Surgeon Kiranjeet Gill has been awarded as one of the 15th ... award that was started in 2003 to salute young achievers in Southwest Florida who ...
(Date:9/21/2017)... GENEVA, IL. (PRWEB) , ... September 21, 2017 ... ... to results released today of a new member survey conducted by the ... hair restoration procedures performed from 2014 to 2016 rose 60 percent, with 635,189 ...
(Date:9/21/2017)... ... 2017 , ... The New England Center for Children® (NECC®), a global leader ... Hung to the Board of Directors. , “The New England Center for Children ... an invaluable addition to our team,” said Vincent Strully, Jr., President and CEO of ...
(Date:9/21/2017)... ... September 21, 2017 , ... Sagora Senior Living, one of ... Kingwood Assisted Living and Memory Care located at 24025 Kingwood Place Drive, Kingwood, ... living apartments, 43 memory care apartments and 23 extended care apartments. Modern floor ...
(Date:9/20/2017)... ... 2017 , ... Collins Concrete Coatings announced that they offer ... safety and cleanliness. This unique flooring system uses silver ion technology to resist ... for its antimicrobial properties. Unlike antibiotics, which kill specific microorganisms, silver ions attack ...
Breaking Medicine News(10 mins):